Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

Please choose the site that is most convenient for you

Study Name: Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
7 locations found

Study Name Unavailable
Location: Denville, New Jersey 07834
New York Presbyterian Hospital Weill Cornell Medical Center
Location: New York City, New York 10021
Hematology/Oncology Specialists
Location: Buffalo, New York 14215
Georgia Cancer Specialtists
Location: Tucker, Georgia 30084
Center of Hope for Cancer and Blood Disorders
Location: Riverdale, Georgia 30274
Goshen Center for Cancer Care
Location: Goshen, Indiana 46526
University of Southern California- Keck School of Medicine
Location: Los Angeles, California 90033

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.